Biden and Sanders unite to tackle skyrocketing drug prices
President Joe Biden and Senator Bernie Sanders are joining forces to address the urgent need to reduce drug costs.
Their joint effort aims to alleviate the financial burden on millions of Americans dependent on inhalers for conditions like asthma.
The Biden administration’s progress in drug pricing aligns with public demands to curb pharmaceutical profiteering.
However, advocates, including Public Citizen’s Access to Medicines program, stress the need for further action.
Biden’s reelection campaign has underscored his commitment to this cause, proposing caps on insulin costs and out-of-pocket expenses for seniors.
The president has emphasized the initiative as a pivotal battle against Big Pharma, recognizing Sanders’ longstanding leadership in the fight for affordable healthcare.